* Phibro Animal Health Corp PAHC.OQ PAHC.O is expected
to show a rise in quarterly revenue when it reports results on
November 2.
* The Teaneck, New Jersey-based company is expected to report a
3.3% increase in revenue to $201.707 million from $195.19
million a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Phibro Animal Health
Corp is for earnings of 29 cents per share. For the same quarter
last year, the company reported earnings of 27 cents per share.
* The current average analyst rating on the shares is "sell" and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and 2 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for Phibro Animal
Health Corp is $20, about 9.7% below its last closing price
of $21.94.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Jun. 30 2021 0.32 0.31 0.32 Beat 2.5
Mar. 31 2021 0.32 0.34 0.34 Met 1.3
Dec. 31 2020 0.27 0.27 0.34 Beat 27.3
Sep. 30 2020 0.20 0.23 0.27 Beat 15.8
Jun. 0.21 0.22 0.17 Missed -22.5
30 2020
Mar. 31 2020 0.34 0.34 0.38 Beat 11.8
Dec. 31 2019 0.29 0.29 0.34 Beat 19.1
Sep. 30 2019 0.24 0.24 0.19 Missed -21.2
This summary was machine generated October 30 at 02:04 GMT. All
figures in US dollars unless otherwise stated